Billionaire Paul Singer's Top 10 Holdings and Recent Moves
Paul Singer is one of the most successful hedge fund managers on Wall Street. He rose to fame by focusing on underperforming companies, launching activist campaigns to unlock value.
Syneos Health Inc. (SYNH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Anson Investments Amin Nathoo And Moez Kassam | 0 | $0 | 0% | |
| 2. | Tudor Investment Corp Paul Tudor Jones | 0 | $0 | 0% | |
| 3. | Clearline Capital Marc Majzner | 0 | $0 | 0% | |
| 4. | Pentwater Capital Management Matthew Halbower | 0 | $0 | 0% | |
| 5. | AQR Capital Management Cliff Asness | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.11 | 8,691 | Director | 17,426 | 2020-07-06 | Filing | |
| $36.65 | 1,300 | Officer | 26,855 | 2020-03-19 | Filing | |
| $36.00 | 45 | Officer | 63,829 | 2020-03-20 | Filing | |
| $36.75 | 3,510 | Officer | 63,784 | 2020-03-20 | Filing | |
| $41.27 | 750 | Officer | 11,314 | 2018-12-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $78.00 | 500 | Officer | 9,342 | 2022-07-28 | Filing | |
| $78.00 | 1,002 | Officer | 47,552 | 2022-07-28 | Filing | |
| $76.00 | 500 | Officer | 9,842 | 2022-07-21 | Filing | |
| $76.00 | 1,002 | Officer | 48,554 | 2022-07-21 | Filing | |
| $75.00 | 2,215 | Officer | 25,292 | 2022-07-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1 | $43 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Here’s Why ClearBridge Investments Small Cap Strategy Sold Syneos Health (SYNH)
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” second quarter 2023 investor letter. A copy of the same can be downloaded here.
Should You Exit Your Position in Syneos Health (SYNH)?
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Syneos Health, Inc. (NASDAQ:SYNH) Q4 2022 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the Syneos Health Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued pharma stocks to buy according to hedge funds.
Is Investing in Syneos Health (SYNH) Risky?
Carillon Tower Advisers, an investment management company, released its “Carillon Chartwell Mid Cap Value Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Is it a Great Move to Invest in Syneos Health (SYNH)?
ClearBridge Investments, an investment management firm, published its “Small Cap Value Strategy” third-quarter 2022 investor letter – a copy of which can be downloaded here.
Syneos Health (SYNH) Detracted From Performance in the Third Quarter
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Australian Billionaire Kerr Neilson is Selling These 15 Stocks
In this article, we discuss the 15 stocks Australian billionaire Kerr Neilson is selling.
10 Pharmaceutical Stocks to Buy Now According to Billionaire Kerr Neilson
In this article, we will look at 10 pharmaceutical stocks to buy now according to billionaire Kerr Neilson.